Stock & Company Details
Cogent Biosciences Inc $COGT
Price:
N/A
N/A
174M
$5.2B
52 Week High:
N/A
10 Day Average Volume:
N/A
-11.96
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
COGT technical indicators
Latest Cogent Biosciences Inc (COGT) indicator readings as of 2026-10-09.
COGT's 14-day RSI is 39.5, in neutral territory. At $31.00 it is trading 14.3% below its 200-day moving average of $36.15, and below its 50-day average of $35.04. Price sits in the middle of its Bollinger Bands ($29.84 to $33.53). ADX reads 27.9, indicating a trending market.
COGT backtested strategy results
How 4 rule-based strategies performed on Cogent Biosciences Inc (COGT) over recent history, last backtested 2026-10-09. Select a strategy to plot its trades on the chart above. Past performance does not predict future results.
| Strategy | Equity curve | Return | Win rate | Trades | Max drawdown |
|---|---|---|---|---|---|
| Oversold Bounce Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | +150.8% | 33% | 18 | -38.3% | |
| Momentum Crossover Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | -77.8% | 20% | 41 | -96.3% | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | +17.2% | 39% | 33 | -65.2% | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | +364.0% | 53% | 32 | -33.2% |
Overview
Cogent Biosciences is a biotechnology company focused on developing precision therapies for genetically defined diseases. The most advanced clinical program, PLX9486, is a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. KIT D816V is responsible for driving systemic mastocytosis, a serious disease caused by unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Cogent Biosciences is headquartered in Cambridge, MA.
Finance Bot
Ask your questions
Start by typing a question below.
